PeptiStar Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Later Stage VC
- Investors
-
24
PeptiStar General Information
Description
Developer of medium-sized molecule pharmaceutical components intended to support drug research, development, and commercial production. The company provides CMC development, process and analytical method development, GMP-compliant manufacturing, and production scale-up for complex compounds such as peptides, oligonucleotide-based substances, and conjugated drug compounds across discovery, clinical development, and commercial stages, enabling pharmaceutical companies to advance drug candidates and maintain stable and compliant manufacturing supply.
Contact Information
Website
www.peptistarinc.comCorporate Office
- 2-5-1 Mishima
- Settsu, Osaka 566-0022
- Japan
Corporate Office
- 2-5-1 Mishima
- Settsu, Osaka 566-0022
- Japan
PeptiStar Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 17-Apr-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Dec-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 20-Apr-2018 | $188M | $188M | Completed | Generating Revenue | |
| 1. Joint Venture | 01-Sep-2017 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PeptiStar Patents
PeptiStar Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026095005-A1 | Production of oligonucleic acid | Pending | 31-Oct-2024 | ||
| JP-7367240-B1 | Particle manufacturing device and frozen particle manufacturing method | Active | 19-May-2022 | ||
| JP-2023171374-A | Particle production device | Pending | 19-May-2022 | ||
| JP-2023171213-A | Particle production device and frozen particle production method | Active | 19-May-2022 | ||
| EP-4365184-A1 | Analysis method for peptide bound to carrier for liquid phase peptide synthesis | Pending | 02-Jul-2021 | G01N30/26 |
PeptiStar Signals
PeptiStar Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Development Bank of Japan | Corporation | Minority | ||
| Shimadzu (Japan) | PE-Backed Company | Minority | ||
| Sumitomo Chemical | Corporation | Minority | ||
| Toagosei | Corporation | Minority | ||
| Asahi Kasei Corporate Venture Capital | Corporate Venture Capital | Minority |
PeptiStar FAQs
-
When was PeptiStar founded?
PeptiStar was founded in 2017.
-
Where is PeptiStar headquartered?
PeptiStar is headquartered in Settsu, Japan.
-
What is the size of PeptiStar?
PeptiStar has 100 total employees.
-
What industry is PeptiStar in?
PeptiStar’s primary industry is Drug Discovery.
-
Is PeptiStar a private or public company?
PeptiStar is a Private company.
-
What is PeptiStar’s current revenue?
The current revenue for PeptiStar is .
-
How much funding has PeptiStar raised over time?
PeptiStar has raised $205M.
-
Who are PeptiStar’s investors?
Development Bank of Japan, Shimadzu (Japan), Sumitomo Chemical, Toagosei, and Asahi Kasei Corporate Venture Capital are 5 of 24 investors who have invested in PeptiStar.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process